Insight journal - Company

Daiichi Sankyo: Partnering activity 2005-2013

Posted on 06 August 2013

Tags: , ,

Daiichi Sankyo has announced over 45 partnering / licensing deals since 2005, with 5 deals in 2012 alone.

Abstracted from: Partnering Agreements with Daiichi Sankyo 2005-2013

The number of partnering, collaborative R&D and licensing deals announced varied year on year with a significant increase in 2011 and gradually decreasing since then.

The following figure shows the level of Daiichi Sankyo partnering deal announcements since 2005.

Figure 1: Daiichi Sankyo partnering deals 2005-2013

Daiich deal activity per year

Source: Current Agreements, 2013

Analysis of the partnering deals shows a strong emphasis on partnerships in oncology, cardiovascular, infective diseases, musculoskeletal and metabolic disease. This reflects the focus areas of Daiichi Sankyo strongly.

The following table provides an overview of the partnering deals announced by Daiichi Sankyo based on therapy area disclosed.

Our report provides more detailed insight into the precise therapeutic target of each deal. See: Partnering Agreements with Daiichi Sankyo 2005-2013

Figure 2: Daiichi Sankyo partnering deals by therapy area 2005-2013

Daiich deal activity by therapy area

Source: Current Agreements, 2013

Further analysis of these deals shows that Daiichi Sankyo has a preference for licensing, co-promotion and collaborative R&D deals quite similar to many other top pharmaceuticals or big biotech companies. Such partnering deals provide the right for Daiichi Sankyo to exploit the licensors technology in return for payment of upfront, development and sales, and royalty payments.

The following table provides an overview of the partnering deals announced by Daiichi Sankyo based on deal type disclosed.

Figure 3: Daiichi Sankyo partnering deals by deal type 2005-2013

Daiich deal activity by deal type

Source: Current Agreements, 2013

When looking at stage of development at partnering deal signing, the most popular stage at signing is discovery with 14 deal announcements.

Daiichi Sankyo is also active in partnering at preclinical, clinical and marketed stage deals. This reflects on their strong research and development operations and their commitment to deliver innovative products.

The following table provides an overview of the partnering deals announced by Daiichi Sankyo based on stage of development at signature.

Figure 4: Daiichi Sankyo partnering by stage of development 2005-2013

Daiich deal activity by stage of development

Source: Current Agreements, 2013

Daiichi Sankyo has signed over 45 partnering, collaborative R&D and licensing deals since 2005. The following provides a summary of the top deals by headline value.

Figure 5: Top Daiichi Sankyo partnering deals by headline value 2005-2013

Daiichi top deals by headline

Source: Current Agreements, 2013

Our report provides more detailed insight into the details of each deal. See: Partnering Agreements with Daiichi Sankyo 2005-2013

Daiichi Sankyo partnering at Current Agreements

View all partnering deals for Daiichi Sankyo:

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

Full details on each deal can be found at CurrentAgreements (subscription required)

 

More

Daiichi Sankyo company profile

Daiichi Sankyo partnering interests

Daiichi Sankyo M&A activity

 

See also

Available reports from Current Partnering

Report: Partnering Agreements with Daiichi Sankyo 2005-2013

Report: Partnering Deals and Alliances with Big Pharma

 

Available resources for deal coverage for Daiichi Sankyo

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Read: more on Daiichi Sankyo company profile, recent partnering, M&A and financing news and articles

 

Related

Report: Practical Guide to Finding Partners

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s M&A Scorecard – view top life science M&A deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

View: Top 50 pharma – overview of top 50 pharmaceutical companies by revenue – partnering activity, deal news, partnering dealtalk

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply